SBI CORPORATION NO 1220 POONGLIM

Poonglim Pharmatech Co., Ltd. is primarily a factory (manufacturer).

Company Introduction:

Poonglim Pharmatech Co., Ltd. is a South Korean manufacturing company that specializes in the production of high-precision medical devices. Established in 1999, the company has grown to become a prominent developer and producer of advanced syringes and needles. It is particularly recognized for its innovative Low Dead Space (LDS) syringes, designed to minimize residual medicine and maximize the number of doses from a single vial, which gained significant attention during global vaccination campaigns. Poonglim Pharmatech is committed to research and development, aiming to provide cutting-edge solutions for the healthcare industry. The company has a notable investment relationship with SBI Investment, a subsidiary of the major financial conglomerate SBI Holdings, indicating its strategic importance and technological capabilities. Its headquarters are located in Gyeonggi-do, South Korea, and it serves both domestic and international markets with its high-quality medical products. The identifier "NO 1220" associated with "SBI CORPORATION" is not a standard part of Poonglim Pharmatech's official name, but it likely indicates a specific fund, investment vehicle, or internal reference used by SBI Corporation in relation to their investment in or association with Poonglim Pharmatech.

SBI CORPORATION NO 1220 POONGLIM is a Korean company. Information about its specific products is not publicly available in detail. Generally, SBI Group companies are involved in a wide range of businesses, including:

* Financial Services: Including venture capital, asset management, and banking.

* Biotechnology: Investment in and development of biotechnology ventures.

* IT and Technology: Investments in IT and technology-related businesses.

* Real Estate: Possibly real estate investment or management.

To obtain specific product information, you would need to contact the company directly or refer to their official website if available.